Tuesday, December 19, 2023 12:21:36 PM
Recent NARI News
- Inari Medical Reports First Quarter 2024 Financial Results • GlobeNewswire Inc. • 04/30/2024 08:05:00 PM
- Inari Medical to Announce First Quarter 2024 Financial Results • GlobeNewswire Inc. • 04/17/2024 08:05:00 PM
- Inari Medical Announces the Release of 2023 Ethos and Sustainability Report • GlobeNewswire Inc. • 04/11/2024 08:05:00 PM
- Inari Medical Strengthens Senior Leadership Team with Addition of Two Executives • GlobeNewswire Inc. • 04/02/2024 08:05:00 PM
- AppFolio Set to Join S&P MidCap 400; Inari Medical to Join S&P SmallCap 600 • PR Newswire (US) • 03/25/2024 10:15:00 PM
- Inari Medical Announces Interim Two-Year Results from the ClotTriever CLOUT Registry • GlobeNewswire Inc. • 03/12/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 09:07:33 PM
- Inari Medical Reports Fourth Quarter 2023 Financial Results • GlobeNewswire Inc. • 02/28/2024 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2024 09:02:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 02:57:42 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 02:55:13 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 02:52:32 AM
- Inari Medical to Announce Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 02/14/2024 09:05:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 11:29:30 AM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 01/31/2024 09:04:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/09/2024 11:33:54 AM
- Inari Medical Announces Preliminary 2023 Revenue and 2024 Guidance • GlobeNewswire Inc. • 01/09/2024 11:30:00 AM
- OKAMI MEDICAL APPOINTS RHONDA ROBB AS PRESIDENT AND CHIEF EXECUTIVE OFFICER • PR Newswire (US) • 01/08/2024 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 05:29:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 05:24:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 05:21:40 PM
- Inari Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 12/20/2023 09:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/14/2023 09:35:52 PM
- Inari Medical Announces First Patient Enrollment in PEERLESS II Randomized Controlled Trial (RCT) • GlobeNewswire Inc. • 11/27/2023 09:20:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/18/2023 12:19:21 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM